Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Dec 4, 2022
Date Accepted: May 24, 2023

The final, peer-reviewed published version of this preprint can be found here:

Characteristics of Interstitial Pneumonia With Autoimmune Features (IPAF): Protocol for a Multicenter Prospective Study

Rzepka-Wrona P, Skoczyński SM, Piotrowski W, Jassem E, Ziora D, Barczyk A

Characteristics of Interstitial Pneumonia With Autoimmune Features (IPAF): Protocol for a Multicenter Prospective Study

JMIR Res Protoc 2023;12:e44802

DOI: 10.2196/44802

PMID: 37976081

PMCID: 10692886

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Characteristics of Interstitial Pneumonia With Autoimmune Features (IPAF) - a Multicenter Prospective Study

  • Patrycja Rzepka-Wrona; 
  • Szymon Michał Skoczyński; 
  • Wojciech Piotrowski; 
  • Ewa Jassem; 
  • Dariusz Ziora; 
  • Adam Barczyk

ABSTRACT

Background:

Interstitial lung disease is a broad term encompassing diseases of different bacgrounds. Interstitial pneumonia with autoimmune features (IPAF) is a recent term, which implies presence of autoimmunity.

Objective:

To provide clinical, serological, functional and radiological characteristics of a sample of Polish IPAF population;compare this population with patients with idiopathic and autoimmunity-induced interstitial pneumonias; search for prognostic and diagnostic biomarkers of IPAF in serum and bronchoalveolar lavage fluid.

Methods:

A multi-center prospective interventional study planned to recruit 240 participants, divided into the study group (IPAF patients) and two control groups (idiopathic interstitial pneumonias and connective tissue disease-associated interstitial pneumonias). Biological fluid samples will be collected according to Polish Respiratory Society management guidelines and will be stored at -80°C for further tests. Prospective 5-year observation is planned to determine clinical stability of IPAF. The study will be carried out according to the Code of Ethics of the World Medical Association (Declaration of Helsinki).

Results:

Not applicable yet.

Conclusions:

This study will be a step towards better understanding of IPAF etiopathogenesis and outcomes. Clinical Trial: ClinicalTrials.gov Identifier: NCT03870828


 Citation

Please cite as:

Rzepka-Wrona P, Skoczyński SM, Piotrowski W, Jassem E, Ziora D, Barczyk A

Characteristics of Interstitial Pneumonia With Autoimmune Features (IPAF): Protocol for a Multicenter Prospective Study

JMIR Res Protoc 2023;12:e44802

DOI: 10.2196/44802

PMID: 37976081

PMCID: 10692886

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.